Harris, E., Sukhanova, M., Abaza, Y., Moreno Vanegas, Y. A., Badar, T., Lin, C., … Saygin, C. (2024). Clinical and Molecular Characterization of TP53-Mutant Acute Lymphoblastic Leukemia. In Blood (Vol. 144, pp. 1425–1425). American Society of Hematology. https://doi.org/10.1182/blood-2024-212213

Harris, Ethan, Madina Sukhanova, Yasmin Abaza, Yenny Alejandra Moreno Vanegas, Talha Badar, Chenyu Lin, Alexander Coltoff, et al. “Clinical and Molecular Characterization of TP53-Mutant Acute Lymphoblastic Leukemia.” In Blood, 144:1425–1425. American Society of Hematology, 2024. https://doi.org/10.1182/blood-2024-212213.

Harris E, Sukhanova M, Abaza Y, Moreno Vanegas YA, Badar T, Lin C, et al. Clinical and Molecular Characterization of TP53-Mutant Acute Lymphoblastic Leukemia. In: Blood. American Society of Hematology; 2024. p. 1425–1425.

Harris, Ethan, et al. “Clinical and Molecular Characterization of TP53-Mutant Acute Lymphoblastic Leukemia.” Blood, vol. 144, no. Supplement 1, American Society of Hematology, 2024, pp. 1425–1425. Crossref, doi:10.1182/blood-2024-212213.

Harris E, Sukhanova M, Abaza Y, Moreno Vanegas YA, Badar T, Lin C, Coltoff A, Patel AA, Wang P, Tjota M, Cheng JX, Gurbuxani S, Venkataraman G, Arber DA, Duvall AS, Drazer MW, Larson RA, Odenike O, Shah BD, Stock W, Aldoss I, Saygin C. Clinical and Molecular Characterization of TP53-Mutant Acute Lymphoblastic Leukemia. Blood. American Society of Hematology; 2024. p. 1425–1425.